Amneal Pharmaceuticals (AMRX) Net Cash Flow (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Net Cash Flow of -$107.5 million for Q1 2026, down 116.94% year-over-year from $634.5 million in Q1 2025, and down 243.84% quarter-over-quarter from $74.7 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Net Cash Flow (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$107.5 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 116.94% year-over-year to -$107.5 million; the TTM figure through Mar 2026 stood at $138.2 million (up 664.6% YoY), while the FY2025 annual figure was $196.2 million, up 865.93% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$107.5 million, down from $74.7 million in the prior quarter.
- The five-year high for Net Cash Flow was $155.4 million in Q3 2025, with the low at -$118.4 million in Q2 2022.
- The 5-year median for Net Cash Flow is -$1.9 million (2022), against an average of -$2.5 million.
- The sharpest annual moves came in 2023 and 2024: Net Cash Flow sank 885.96% in 2023, then surged 1137.19% in 2024.
- Amneal Pharmaceuticals' Net Cash Flow stood at -$56.9 million in 2022, then soared by 105.8% to $3.3 million in 2023, then soared by 1137.19% to $40.8 million in 2024, then jumped by 83.12% to $74.7 million in 2025, then slumped by 243.84% to -$107.5 million in 2026.
- Business Quant data shows AMRX's Net Cash Flow at -$107.5 million in Q1 2026, $74.7 million in Q4 2025, and $155.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | -64.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -64.63 Mn |
| Jun 30, 2026 | -64.63 Mn |
| Mar 31, 2026 | -107.51 Mn |
| Mar 31, 2026 | -107.51 Mn |
| Dec 31, 2025 | 74.74 Mn |
| Dec 31, 2025 | 74.74 Mn |
| Sep 30, 2025 | 155.43 Mn |
| Sep 30, 2025 | 155.43 Mn |
| Jun 30, 2025 | 15.59 Mn |
| Jun 30, 2025 | 15.59 Mn |
| Mar 31, 2025 | -49.56 Mn |
| Mar 31, 2025 | -49.56 Mn |
| Dec 31, 2024 | 40.82 Mn |
| Dec 31, 2024 | 40.82 Mn |
| Sep 30, 2024 | 28.72 Mn |
| Sep 30, 2024 | 28.72 Mn |
| Jun 30, 2024 | -1.89 Mn |
| Jun 30, 2024 | -1.89 Mn |
| Mar 31, 2024 | -47.33 Mn |
| Mar 31, 2024 | -47.33 Mn |